STRYKER CORPORATION
Last · NYSE$281.63-0.92 (-0.33%)close · yahoo · 13h ago
Market cap$108.03B383.6M sh
P/E · TTM29.2fwd 16.9 · eps 9.65
Beta0.78vs S&P 500
Div yield1.23%annual · TTM
52w range
$267.00$392.55
Volume1.8Msession
| Revenue | $25.8B |
|---|---|
| Operating income | $5.5B |
| Net income | $3.7B |
| Free cash flow | $4.7B |
| Operating margin | 21.4% |
| Net margin | 14.4% |
| Return on equity | 15.5% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2025-02-12
- Sales Growth
- Adjusted Earnings
- Impairment Risk
- Debt Load
- Acquisition Execution
- Supply Chain
- Pricing Pressure
- Regulatory Risk
Red flags
- Goodwill and other impairments reached $977 million in 2024 versus $36 million in 2023, materially reducing GAAP earnings.
- Total debt increased to $13.597 billion from $12.995 billion, while 2024 acquisition upfront payments were $1.628 billion plus up to $400 million of contingent consideration.
- The company recorded $202 million of accruals for product-liability matters and is investigating possible FCPA violations with SEC and DOJ involvement; outcomes remain unpredictable.
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
$3.56
Est. revenue
6.6B
Earnings transcripts
- Issuer webcast
Q2 2026 earnings call transcript
STRYKER CORPORATION
- Issuer webcast
Q3 2019 earnings call transcript
STRYKER CORPORATION
- Issuer webcast
Q2 2019 earnings call transcript
STRYKER CORPORATION
- Issuer webcast
Q1 2019 earnings call transcript
STRYKER CORPORATION
- Issuer webcast
Q4 2018 earnings call transcript
STRYKER CORPORATION
- Issuer webcast
Q1 2018 earnings call transcript
STRYKER CORPORATION
Press & signals
- GlobeNewswire
Stryker announces leadership succession
- GlobeNewswire
Stryker to announce third quarter 2026 financial results
- GlobeNewswire
Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering
The rest of this company's wire — with summaries and source links — is part of Pro.
See plans